Pablo Larrea

Pablo Larrea has a diverse range of work experience in scientific research and analysis. Pablo started their career as a Laboratory Technician Assistant at Worcester State University in 2013, where they prepared and set up experiments for various chemistry courses. In 2014, they worked as a Research Assistant at Harvard University School of Public Health, where they conducted data analysis and research on the effects of coffee consumption on diabetes.

In 2015, Larrea worked as a Research Assistant at Brigham and Women's Hospital, assisting with metabolomic and lipidomic research in the Neurosurgery department. Pablo also gained experience in liquid chromatography-mass spectrometry (LC-MS) and lipid extraction techniques. Later that year, they joined Merrimack Pharmaceuticals as a QC Analyst, focusing on quality control in the pharmaceutical industry.

Larrea then moved on to AbbVie in 2017, where they worked as a Chemist 2, specializing in analysis of glycoproteins and method development for high-performance liquid chromatography (HPLC). Pablo continued their work in HPLC at Ipsen in 2018 as a QC Chemistry Associate, performing assays and providing guidance to junior analysts in a GMP environment.

In 2019, Larrea joined Repligen Corporation as a QC Analyst 2, further expanding their experience in quality control. Pablo later returned to AbbVie in the same year, taking on roles as an Associate Scientist 2 and Scientist 1, involving scientific research and analysis.

Most recently, Larrea has joined Ring Therapeutics in 2023 as a Scientist 1, focusing on novel therapeutic development. Throughout their career, Larrea has demonstrated a strong background in scientific research and analysis, with expertise in techniques such as HPLC and LC-MS.

Pablo Larrea completed their education from 2010 to 2014 at Worcester State University, where they obtained Bachelor's degrees in Chemistry and Biology.